Abstract
Autoimmune diseases are chronic and debilitating disorders in which the body mounts an abnormal immune response against its own organs and tissues.
Myriad RBM is a leader in the field of biomarker testing, offering comprehensive, quantitative and sensitive measurement of hundreds of protein biomarkers using multi-analyte profiling (MAP) technology. Our biomarker panels have been a key component of numerous studies covering a variety of autoimmune disorders, including Crohn’s disease, rheumatoid arthritis (RA), psoriasis and systemic lupus erythematosus (SLE).
